Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2002, p. 2761-2768, Vol. 22, No. 8
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.8.2761-2768.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Institute of Pharmacology,1 Institute of Animal Research, Medical Faculty, Technical University of Aachen, D-52057 Aachen,4 Department of Biochemistry, University of Kiel, D-24118 Kiel,2 Department of Anatomy and Cell Biology, University of Marburg, D-35037 Marburg, Germany3
Received 14 November 2001/ Returned for modification 18 December 2001/ Accepted 15 January 2002
|
|
|---|
|
|
|---|
in a GTP-independent manner. In addition, ARL4 was detected in the nucleus and also in the nucleolus by indirect immunofluorescence (13). Among the ARF-like GTPases, ARL4 is particularly interesting because of its differential expression in the 3T3-L1 preadipocyte cell line (18). ARL4 mRNA was undetectable in undifferentiated 3T3-L1 cells and abundant in differentiated cells. In addition, ARL4 has been shown to be developmentally expressed during mouse embryogenesis. mRNA of ARL4 appears transiently at days 8.5 to 10.5 in a rostro-caudal direction, suggesting that ARL4 is involved in somite formation and central nervous system differentiation (13). ARL4 mRNA was also detected in several adult tissues, e.g., testis, muscle, spleen, and brain. In testis, ARL4 mRNA was exclusively detected in the pubertal and adult glands, but not in the prepubertal gland (8). Interestingly, the strong expression in adult testis is driven by a separate, testis-specific promoter (8).
The aim of the present study was to investigate the role of ARL4 in embryonic development, germ cell proliferation and differentiation. We identified the time point of ARL4 induction during testicular development and the localization of ARL4 in the seminiferous tubule. In addition, an Arl4-null mutant was generated and characterized with regard to fertility and sperm count. The data indicate that disruption of the Arl4 gene produces a significant reduction of sperm count without affecting fertility. In addition, the data indicate that ARL4 is dispensable for embryonal development or adipogenesis.
|
|
|---|
-32P]dCTP by random oligonucleotide priming. The nylon membranes were hybridized at 42°C, and blots were washed twice with 0.8% SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) containing 0.1% sodium dodecyl sulfate. Immunohistochemical detection of ARL4 in testis. Immunolocalization of ARL4 was performed with a polyclonal rabbit antiserum against the C terminus of ARL4. Frozen tissue sections were dried and fixed with 4% paraformaldehyde for 15 min. Endogenous peroxidase was blocked with 3% H2O2. Nonspecific antibody binding was blocked with 50% normal goat serum (Dianova, Hamburg, Germany). Testis sections were incubated with anti-ARL4 antibody in a dilution of 1:150 for 2 h at 37°C, and immunostaining was performed with a peroxidase-conjugated goat anti-rabbit immunoglobulin in a dilution of 1:100 (Dianova). The sections were counterstained with Mayer's hematoxylin.
Construction of the Arl4-targeting vector and generation of Arl4-mutant mice. A neomycin resistance cassette was inserted into the XmnI and XhoI sites of exon 2 of the Arl4 gene, thereby introducing diagnostic EcoRI and NcoI sites. Mouse embryonic stem (ES) cells were transfected by electroporation with the linearized Arl4 targeting vector and were then cultured in the presence of 335 µg of G418 (Geneticin) per ml. Eighty-four neomycin-resistant ES clones were picked, and their genomic DNA was isolated and digested with EcoRI and NcoI. Correctly targeted clones were identified by Southern blot analysis with a 5' external probe (nucleotides -2503 to -1803). One ES cell clone that had incorporated the targeting vector by homologous recombination was used for microinjection of C57BL/6J blastocyts, which were subsequently transferred into a pseudopregnant foster mouse. Chimeric males were mated with C57BL/6J females. Heterozygote offspring were mated, and genomic DNA was isolated from tail biopsies, digested with EcoRI and NcoI, and analyzed by Southern blotting using the 5' external probe or by PCR using primers for amplification of both the neo gene and Arl4 (upstream, 5'-CAATCGCGTAGCCCGATCAC-3'; downstream, 5'-AGGTACTGCCATTCATCTCTTC-3'; nucleotides 2104 to 2123 and 2784 to 2805 in the Arl4 genomic sequence).
Preparation of spermatozoa. Caudae epididymidis and vasa deferentia were excised and then rinsed with medium containing 150 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 30 mM HEPES, 10 mM glucose, 10 mM lactic acid, and 1 mM pyruvic acid (pH 7.4). After transfer to 1 ml of medium supplemented with 5 mg of bovine serum albumin per ml and 15 mM NaHCO3, semen was allowed to exude (15 min at 37°C, 5% CO2) from three to five small incisions. Cells were diluted to 4 ml and collected twice by sedimentation (400 x g; 5 min [20]). The sperm count and motility of the sperm cells were analyzed with a CASA (computer-assisted sperm analyzer) as described by Krause (10).
|
|
|---|
![]() View larger version (154K): [in a new window] |
FIG. 1. Expression of ARL4 in seminiferous tubules. Frozen sections of testis from adult mice were fixed with formaldehyde and incubated with an antiserum against the C terminus of ARL4. The immunostaining was performed with peroxidase-conjugated goat anti-rabbit immunoglobulin and analyzed at a magnification of x400. The sections were counterstained with Mayer's hematoxylin for 10 min. IT, interstitial tissues; L, lumen; S, spermatides; SC, spermatocytes; SG, spermatogonia.
|
![]() ![]() View larger version (124K): [in a new window] |
FIG. 2. Time course of expression of ARL4 during testis development. (A) Northern blot analysis of ARL4 expression in testes from mice of different ages. Total RNA was isolated from testes of mice at 10 to 30 days of age and analyzed in Northern blots with a probe derived from the full-length cDNA of rat ARL4. (B) Immunohistochemical detection of ARL4 in testis tissues from 18-, 24-, and 30-day-old mice. Frozen sections of mouse testes at the ages indicated were fixed with formaldehyde and immunostained with the ARL4 antiserum as described for Fig. 1. For better visualization of immunostaining, counterstaining with Mayer's hematoxylin was performed only for 1 min.
|
![]() View larger version (37K): [in a new window] |
FIG. 3. Targeted disruption of the Arl4 gene by homologous recombination. (A) Organization of the Arl4 gene, targeting construct, and organization of the disrupted Arl4 allele. The neo cassette was inserted into the XmnI and XhoI sites of exon 2, introducing diagnostic EcoRI and NcoI sites. Relevant restriction sites: B, BamHI; E, EcoRI; Nc, NcoI; Es, EscI; Xm, XmnI; X, XhoI; P, PstI. The position of the 5' probe for Southern blot analysis is indicated (bp -2503 to -1803). (B) Southern blot of several ES cell clones. DNA was digested with EcoRI and analyzed with the 5' probe. The arrow designates a clone that incorporated the targeting vector by homologous recombination; this clone was used for injection into blastocysts. (C) Southern blot analysis of genomic DNA from the F2 progeny (neonate tail DNA). The DNA was digested with NcoI and hybridized with the 5' probe. The positions of the wild-type allele (10 kb) and the targeted allele (4.9 kb) are indicated.
|
Arl4 mRNA was absent in the testis, spleen, and intestine tissues of Arl4-null mutants and was significantly reduced in heterozygotes (Arl4+/-) (Fig. 4A). In order to demonstrate the absence of the protein, we analyzed sections of testes from wild-type and Arl4-/- mutants by immunohistochemistry with antiserum against a C-terminal peptide of ARL4. Figure 4C illustrates that no ARL4 immunoreactivity was detected in sections of testes from Arl4-/- mice (Fig. 4C, right panel).
![]() ![]() View larger version (108K): [in a new window] |
FIG.4. Expression of ARL4 mRNA and ARL4 protein. (A) Northern blot analysis of the expression of ARL4 in different tissues of Arl4+/+, Arl4+/-, and Arl4-/- mutants. Northern blots of total RNA (10 µg) from the indicated tissues were hybridized with a probe derived from full-length rat ARL4 cDNA. (B) Northern blot analysis of the expression of ARL6 and ARL7 in spleen, intestine, and testis tissues of Arl4+/+, Arl4+/-, and Arl4-/- mutants. Northern blots of total RNA (10 µg) from the indicated tissues were hybridized with a probe derived from ARL6 or ARL7 cDNA. (C) Immunohistochemical detection of ARL4 in seminiferous tubules. Frozen sections of testes from adult Arl4+/+ (left panel) or Arl4-/- (right panel) mice were fixed with formaldehyde and incubated with the ARL4 antiserum. The immunostaining was performed with peroxidase-conjugated goat anti-rabbit immunoglobulin and analyzed at a magnification of x400. The sections were counterstained with Mayer's hematoxylin.
|
Characteristics of Arl4-/- mice. Arl4-/- mice were viable, with normal growth and no apparent abnormality. In sections from several tissues (brain, thymus, spleen, intestine, fat) from 3- and 12-month-old male and female Arl4-/- mice, no morphological or pathological abnormalities were observed (data not shown). Body weights and body lengths of wild-type and knockout mice were identical. In contrast, the weights of testes were significantly reduced in Arl4-/- mice (Table 1).
|
View this table: [in a new window] |
TABLE 1. Body weight and length and reproductive data of Arl4-/- male mice
|
![]() View larger version (42K): [in a new window] |
FIG. 5. Sperm count and sperm motility from Arl4+/+, Arl4+/-, and Arl4-/- mice. (A) Spermatozoa were isolated from epididymal tissues of 6-month-old Arl4+/+, Arl4+/-, and Arl4-/- mice and counted (left panel), and their motility (right panel) was analyzed as described in Materials and Methods (means ± SEM from six Arl4+/+ and Arl4-/- mice and from three Arl4+/- mice). (B) Sections of testes from 9-month-old mice were stained with Mayer's hematoxylin. Tubules containing spermatozoa were counted and normalized per 100 tubules (left panel); spermatozoa were counted and normalized per 100 spermatogonia (right panel; means ± SEM from five animals are shown). Asterisks indicate statistical significance (P < 0.001, one-way analysis of variance (panel A) or t test (panel B).
|
Adipose tissue weight, serum metabolites, and blood cell count in Arl4 mutants. Since we have previously shown that ARL4 is differentially expressed in 3T3-L1 adipocytes (18), we expected a defect in the development of adipose tissues. We therefore analyzed the weights of epididymal fat pads and determined several metabolic parameters of Arl4+/+ and Arl4-/- mice. Epididymal fat pad weights obtained from Arl4-/- mice were not significantly different from those of the Arl4+/+ littermates (Table 2). In addition, we failed to detect any differences in blood glucose levels, serum cholesterol, serum triglycerides, or blood cell counts (Table 2).
|
View this table: [in a new window] |
TABLE 2. Adipose tissue weight, serum metabolite, and blood cell characteristics of Arl4-/- micea
|
|
|
|---|
Several knockout mice with reduced sperm count but normal fertility have been described previously. Mice lacking the centromere protein B exhibit a phenotype which is very similar to that of the Arl4-null mutant. Centromere protein B is a DNA binding protein required for meiosis; its deletion caused a reduction in testis weight by 30% and reduction in the sperm count by 40% without a reduction in fertility (7). Furthermore, mice lacking the follicle-stimulating hormone ß (FSHß) are fertile despite reduced testis size and number of Sertoli cells (11). Activin II receptor A (ActRcIIA)-null mutants exhibit reduced serum FSH levels, decreased testis size, and reduced Sertoli cell number but are also fertile (14). Even the double mutants lacking both FSHß and ActRcIIA are fertile, although their numbers of spermatozoa were even lower than those of the single FSHß or ActRcIIA gene knockout mice (12).
The cellular function of ARL4 is largely unknown. The protein carries a nuclear localization signal in its C terminus and is predominantly located in the nucleus (8, 13). Furthermore, it appears to shuttle between the nucleus and intracellular organelles (endoplasmic reticulum and/or Golgi) depending on its GTP/GDP-binding status (A. Schürmann and H.-G. Joost, unpublished data). Thus, it appears possible that ARL4 is involved in the regulation of protein transport from or to the nucleus during the division or differentiation of cells.
The next relatives of ARL4 are the ARF-like proteins ARL6 and ARL7 (9). Both GTPases have the C-terminal nuclear localization motif and exhibit GTP-binding and exchange characteristics similar to those of ARL4 (9). ARL7 is expressed in spleen but not in testis, whereas high levels of ARL6 mRNA are found in testis. ARL4 and ARL6 share 61% identical amino acids with stretches of 80% identity. Thus, ARL6 is a potential candidate to compensate a loss of function of ARL4. Since Arl6 mRNA levels in spleen tissues of Arl4-null mutants were higher than those of control animals, Arl6 appears to be upregulated in this tissue, suggesting that ARL4 and ARL6 play a specific role in spleen. In contrast, no upregulation of mRNA levels of ARL7 in spleen and of ARL6 in all other tissues was detected. However, the possibility cannot be excluded that the normal transcript levels of ARL6 and ARL7 are sufficient to partially compensate the lack of ARL4.
Based on its differential expression in 3T3-L1 adipocytes (18) and on its specific localization of expression during embryogenesis (13), we had anticipated that mice lacking Arl4 would exhibit developmental abnormalities and/or an impairment of adipogenesis. Although we cannot rule out a subtle phenotype that escaped our preliminary characterization, the present data strongly argue against an essential role of ARL4 in adipogenesis or neurogenesis and suggest that its main function is related to the development of male germ cells.
The skillful technical assistance of Ursula Braam, Silvia Detro-Dassen, and Petra Kehrer is gratefully acknowledged.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»